ENANTA PHARMACEUTICALS
Enanta Pharmaceuticals, Inc., a research and development company, engages in the discovery, development, and promotion of small molecule drugs in the areas of anti-infective. It develops protease, NS5A, polymerase, and cyclophilin-based inhibitors for the treatment of hepatitis C virus (HCV). The company also develops ABT-450/r, an oral protease inhibitor for the treatment of hepatitis C (HCV) infection. In addition, it develops Bicyclolides, a macrolide antibiotic, which overcomes bacteri... al resistance; and EDP-420, a bicyclolide antibiotic for the treatment of community-acquired pneumonia. The company's antibacterial focus areas include superbugs, respiratory tract infections, and intravenous and oral treatments for hospital and community MRSA. The company has strategic alliances with Abbott Laboratories; and Shionogi & Co., LTD. Enanta Pharmaceuticals, Inc. was formerly known as NovirX, Inc. and changed its name to Enanta Pharmaceuticals, Inc. in May 1999. The company was founded in 1998 and is based in Watertown, Massachusetts.
ENANTA PHARMACEUTICALS
Social Links:
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
1998-01-01
Address:
Watertown, Massachusetts, United States
Country:
United States
Website Url:
http://www.enanta.com
Total Employee:
51+
Status:
Active
Contact:
6176070530
Email Addresses:
[email protected]
Total Funding:
84.6 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Apple Mobile Web Clips Icon WordPress Google Universal Analytics Font Awesome Domain Not Resolving
Similar Organizations
Idera Pharmaceuticals
Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.
Current Advisors List
Current Employees Featured
Stock Details
Investors List
Thuja Capital
Thuja Capital investment in Venture Round - Enanta Pharmaceuticals
Bioventures Investors
Bioventures Investors investment in Venture Round - Enanta Pharmaceuticals
Techno Venture Management
Techno Venture Management investment in Venture Round - Enanta Pharmaceuticals
Oxford Bioscience Partners
Oxford Bioscience Partners investment in Venture Round - Enanta Pharmaceuticals
Advent International
Advent International investment in Venture Round - Enanta Pharmaceuticals
Oxford Bioscience Partners
Oxford Bioscience Partners investment in Venture Round - Enanta Pharmaceuticals
Bioventures Investors
Bioventures Investors investment in Venture Round - Enanta Pharmaceuticals
Swiss Life Private Equity Partners
Swiss Life Private Equity Partners investment in Venture Round - Enanta Pharmaceuticals
Wheatley MedTech Partners
Wheatley MedTech Partners investment in Venture Round - Enanta Pharmaceuticals
Yasuda Enterprise Development
Yasuda Enterprise Development investment in Venture Round - Enanta Pharmaceuticals
Key Employee Changes
| Date | New article |
|---|---|
| 2022-08-08 | Enanta Pharmaceuticals Appoints Scott T. Rottinghaus, M.D., as Senior Vice President and Chief Medical Officer |
Official Site Inspections
http://www.enanta.com Semrush global rank: 226.61 K Semrush visits lastest month: 320.13 K
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
